Delft-based Bi/ond, a biotechnology company specialised in drug discovery, is set to cease its operations. Cinzia Silvestri, the ...
Vigneshwar Ravichandran
|
April 9, 2025
After the end of Q1 2025, it’s clear that Dutch startups are entering the year with renewed strength ...
Vishal Singh
April 7, 2025
AI-powered digital twins help interpret early signals in a small Phase 2a study of a novel therapy for ...
Business Wire
April 3, 2025
The collaboration provides external validation of MultiOmic Health’s AI-enabled precision medicine discovery platform and innovative renal therapeutic programs ...
April 2, 2025
As Q1 2025 comes to a close, it’s clear that Dutch startups are off to a strong start ...
Leuven, Belgium-based Augustine Therapeutics NV, a biotechnology company, has secured €77.7M in an oversubscribed Series A funding round ...
March 24, 2025
Biovelocita II attracts robust support from leading pharmaceutical companies, including Amgen, Bristol Myers Squibb, and Pfizer Ventures The ...
March 18, 2025
Groningen-based Cortalix, a Dutch biotech startup, has raised €1M in funding from Future Tech Ventures, the Rabobank Innovation ...
March 10, 2025
Amid numerous funding rounds, acquisitions, and innovation announcements, it’s easy to overlook some of the quieter, yet equally ...
March 8, 2025
Improvements in fibrosis observed using 3 pre-specified methods of histological analysis: conventional, AIM-MASH (PathAI) and qFibrosis (Histoindex) Mechanistically, ...
March 6, 2025
Total deal value of up to $354 million in upfront, development, and commercial milestone payments per target plus ...
March 3, 2025
Vienna-based Fund F, a venture capital fund, announced that it has closed its first fund oversubscribed at €28M, ...
February 25, 2025
01
02
03
04
05
More
[wp_dark_mode style="2"]
01
From telecom veteran to Dutch Startup Visa success: The Jignesh Dave story